Status

Peptides by US legal status

By Peptide America · Publisher

Each of the 40 molecules in the index holds exactly one of four positions under United States law. The position decides what a reader can lawfully obtain: an approved product, a prescription compounded by a 503A pharmacy, nothing yet while rulemaking is pending, or nothing at all.

  1. FDA-Approved Peptides

    The peptides in this index with an FDA-approved product: what approval establishes, which molecules hold it, and where compounded copies stand. Dated.

    10 molecules: Tesamorelin, Semaglutide, Tirzepatide, Setmelanotide, PT-141, Liraglutide, and 4 more

  2. Peptides Compoundable Under 503A

    What a licensed 503A pharmacy may compound today, molecule by molecule, and what Category 1 listing does and does not mean. Each status dated.

    5 molecules: Sermorelin, NAD+, Glutathione, GHK-Cu, Vasoactive intestinal peptide

  3. The July 2026 PCAC Vote, Explained

    PCAC voted to recommend BPC-157, TB-500, MOTS-c, KPV, Epitalon, and Semax for the 503A list in July 2026. What the votes mean and what is still unlawful.

    6 molecules: BPC-157, MOTS-c, TB-500, KPV, Semax, Epitalon

  4. Peptides With No Lawful US Route

    Peptides with withdrawn nominations, a refused advisory vote, or a standing Category 2 listing: GHK-Cu injectable, DSIP, kisspeptin-10. Gray is not green.

    19 molecules: CJC-1295, Ipamorelin, DSIP, Melanotan II, LL-37, Dihexa, and 13 more

The other way through

A status answers what may lawfully be done with a molecule; a class answers what it is. The molecule index holds every row at once, with filters for both.